Obesity and inflammation: Reduced cytokine expression due to resveratrol in a human in-vitro model of inflamed adipose tissue

Frontiers in Pharmacology

Volumn 6, Issue MAR, 2015, Pages

  Zagotta, Ivana ^a   Dimova, Elitsa Y ^b   Debatin, K M ^a   Wabitsch, Martin ^a   Kietzmann, Thomas ^b   Fischer Posovszky, Pamela ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; RESVERATROL;

ADIPOCYTE; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IL 6 GENE; IL 8 GENE; IN VITRO STUDY; INFLAMMATION; MCP 1 GENE; OBESITY; PROTEIN EXPRESSION;

EID: 84926677208     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00079     Document Type: Article

References (61)

1. Ahn, J., Lee, H., Kim, S., and Ha, T. (2007). Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 364, 972-977
2. Ajuwon, K.M., Jacobi, S.K., Kuske, J.L., and Spurlock, M.E. (2004). Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R547-53
3. Ajuwon, K.M. and Spurlock, M.E. (2005). Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-5
4. Barger, J.L., Kayo, T., Vann, J.M., Arias, E.B., Wang, J., Hacker, T.A., Wang, Y., et al. (2008). A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS. One. 3, e2264
5. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342
6. Bouloumie, A., Curat, C.A., Sengenes, C., Lolmede, K., Miranville, A., and Busse, R. (2005). Role of macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care 8, 347-354
7. De Ferranti, S.D. and Osganian, S.K. (2007). Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc. Dis. Res. 4, 285-296
8. Deo, R., Khera, A., McGuire, D.K., Murphy, S.A., Meo Neto Jde, P., Morrow, D.A., and de Lemos, J.A. (2004). Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 44, 1812-1818
9. Derosa, G., Fogari, E., D'Angelo, A., Bianchi, L., Bonaventura, A., Romano, D., and Maffioli, P. (2013). Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 36, 914-920
10. Fain, J.N. and Madan, A.K. (2005). Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism 54, 220-226
11. Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K.M., Fulda, S., and Wabitsch, M. (2010). Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am. J. Clin. Nutr. 92, 5-15
12. Fischer-Posovszky, P., Newell, F.S., Wabitsch, M., and Tornqvist, H.E. (2008). Human SGBS cells - a unique tool for studies of human fat cell biology. Obes. Facts. 1, 184-189
13. Gonzales, A.M. and Orlando, R.A. (2008). Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr. Metab. (Lond) 5, 17-7075-5-17
14. Gregor, M.F. and Hotamisligil, G.S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445
15. Hauner, H., Skurk, T., and Wabitsch, M. (2001). Cultures of human adipose precursor cells. Methods Mol. Biol. 155, 239-247
16. Herder, C., Haastert, B., Muller-Scholze, S., Koenig, W., Thorand, B., Holle, R., Wichmann, H.E., Scherbaum, W.A., Martin, S., and Kolb, H. (2005). Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54 Suppl 2, S11-7
17. Hotamisligil, G.S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867
18. Kang, L., Heng, W., Yuan, A., Baolin, L., and Fang, H. (2010). Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses. Biochimie 92, 789-796
19. Keuper, M., Dzyakanchuk, A., Amrein, K.E., Wabitsch, M., and Fischer-Posovszky, P. (2011). THP-1 Macrophages and SGBS Adipocytes - A New Human in vitro Model System of Inflamed Adipose Tissue. Front Endocrinol. (Lausanne) 2, 89
20. Kobashi, C., Urakaze, M., Kishida, M., Kibayashi, E., Kobayashi, H., Kihara, S., Funahashi, T., et al. (2005). Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res. 97, 1245-1252
21. Kotnik, P., Keuper, M., Wabitsch, M., and Fischer-Posovszky, P. (2013). Interleukin-1beta Downregulates RBP4 Secretion in Human Adipocytes. PLoS. One. 8, e57796
22. Kundu, J.K. and Surh, Y.J. (2004). Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 555, 65-80
23. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122
24. Larson-Meyer, D.E., Newcomer, B.R., Heilbronn, L.K., Volaufova, J., Smith, S.R., Alfonso, A.J., Lefevre, M., et al. (2008). Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16, 1355-1362
25. Lasa, A., Schweiger, M., Kotzbeck, P., Churruca, I., Simon, E., Zechner, R., and Portillo, M.P. (2012). Resveratrol regulates lipolysis via adipose triglyceride lipase. J. Nutr. Biochem. 23, 379-384
26. Lin, Q.Q., Yan, C.F., Lin, R., Zhang, J.Y., Wang, W.R., Yang, L.N., and Zhang, K.F. (2012). SIRT1 regulates TNF-alpha-induced expression of CD40 in 3T3-L1 adipocytes via NF-kappaB pathway. Cytokine 60, 447-455
27. Loskutoff, D.J. and Samad, F. (1998). The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler. Thromb. Vasc. Biol. 18, 1-6
28. Lyon, C.J. and Hsueh, W.A. (2003). Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am. J. Med. 115 Suppl 8A, 62S-68S
29. Mader, I., Wabitsch, M., Debatin, K.M., Fischer-Posovszky, P., and Fulda, S. (2010). Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. FASEB J. 24, 1997-2009
30. Madrid, L.V., Mayo, M.W., Reuther, J.Y., and Baldwin, A.S., Jr (2001). Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940
31. Maury, E. and Brichard, S.M. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 314, 1-16
32. Miranda, S., Gonzalez-Rodriguez, A., Revuelta-Cervantes, J., Rondinone, C.M., and Valverde, A.M. (2010). Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli. Cell. Signal. 22, 645-659
33. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Klein, S., and Coppack, S.W. (1997). Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82, 4196-4200
34. Morange, P.E., Alessi, M.C., Verdier, M., Casanova, D., Magalon, G., and Juhan, V.I. (1999). PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level. Arterioscler. Thromb. Vasc. Biol. 19, 1361-1365
35. Olholm, J., Paulsen, S.K., Cullberg, K.B., Richelsen, B., and Pedersen, S.B. (2010). Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int. J. Obes. (Lond) 34, 1546-1553
36. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M., and Donner, D.B. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85
37. Path, G., Bornstein, S.R., Gurniak, M., Chrousos, G.P., Scherbaum, W.A., and Hauner, H. (2001). Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J. Clin. Endocrinol. Metab. 86, 2281-2288
38. Pearson, K.J., Baur, J.A., Lewis, K.N., Peshkin, L., Price, N.L., Labinskyy, N., Swindell, W.R., et al. (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157-168
39. Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M., and Tschop, M.H. (2008). Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U. S. A. 105, 9793-9798
40. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado, D.O., Leid, M., McBurney, M.W., and Guarente, L. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776
41. Poulsen, M.M., Vestergaard, P.F., Clasen, B.F., Radko, Y., Christensen, L.P., Stodkilde-Jorgensen, H., Moller, N., Jessen, N., Pedersen, S.B., and Jorgensen, J.O. (2013). High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186-1195
42. Rivera, L., Moron, R., Zarzuelo, A., and Galisteo, M. (2009). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 77, 1053-1063
43. Rocha, K.K., Souza, G.A., Ebaid, G.X., Seiva, F.R., Cataneo, A.C., and Novelli, E.L. (2009). Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem. Toxicol. 47, 1362-1367
44. Rosenow, A., Noben, J.P., Jocken, J., Kallendrusch, S., Fischer-Posovszky, P., Mariman, E.C., and Renes, J. (2012). Resveratrol-induced changes of the human adipocyte secretion profile. J. Proteome Res. 11, 4733-4743
45. Salminen, A., Hyttinen, J.M., and Kaarniranta, K. (2011). AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl) 89, 667-676
46. Serrano-Marco, L., Chacon, M.R., Maymo-Masip, E., Barroso, E., Salvado, L., Wabitsch, M., Garrido-Sanchez, L., et al. (2012). TNF-alpha inhibits PPARbeta/delta activity and SIRT1 expression through NF-kappaB in human adipocytes. Biochim. Biophys. Acta 1821, 1177-1185
47. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., et al. (1996). Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2, 800-803
48. Signorelli, P. and Ghidoni, R. (2005). Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466
49. Skurk, T., van Harmelen, V., Lee, Y.M., Wirth, A., and Hauner, H. (2002). Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. Horm. Metab. Res. 34, 659-663
50. Timmers, S., Konings, E., Bilet, L., Houtkooper, R.H., van de Weijer, T., Goossens, G.H., Hoeks, J., et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell. Metab. 14, 612-622
51. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, M.J., Garcia-Almagro, F.J., Ruiz-Ros, J.A., Tomas-Barberan, F.A., Garcia-Conesa, M.T., and Espin, J.C. (2013a). Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 27, 37-48
52. Tome-Carneiro, J., Larrosa, M., Yanez-Gascon, M.J., Davalos, A., Gil-Zamorano, J., Gonzalvez, M., Garcia-Almagro, F.J., et al. (2013b). One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res. 72, 69-82
53. Vicennati, V., Vottero, A., Friedman, C., and Papanicolaou, D.A. (2002). Hormonal regulation of interleukin-6 production in human adipocytes. Int. J. Obes. Relat. Metab. Disord. 26, 905-911
54. Wabitsch, M., Brenner, R.E., Melzner, I., Braun, M., Moller, P., Heinze, E., Debatin, K.M., and Hauner, H. (2001). Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. Relat. Metab. Disord. 25, 8-15
55. Wang, A., Liu, M., Liu, X., Dong, L.Q., Glickman, R.D., Slaga, T.J., Zhou, Z., and Liu, F. (2011). Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J. Biol. Chem. 286, 60-66
56. Warnberg, J., Nova, E., Moreno, L.A., Romeo, J., Mesana, M.I., Ruiz, J.R., Ortega, F.B., et al. (2006). Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am. J. Clin. Nutr. 84, 505-512
57. Yang, R.Z., Lee, M.J., Hu, H., Pollin, T.I., Ryan, A.S., Nicklas, B.J., Snitker, S., et al. (2006). Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 3, e287
58. Yen, G.C., Chen, Y.C., Chang, W.T., and Hsu, C.L. (2011). Effects of polyphenolic compounds on tumor necrosis factor-alpha (TNF-alpha)-induced changes of adipokines and oxidative stress in 3T3-L1 adipocytes. J. Agric. Food Chem. 59, 546-551
59. Yoshizaki, T., Milne, J.C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J.L., Lu, J.C., Smith, J.J., Jirousek, M.R., and Olefsky, J.M. (2009). SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell. Biol. 29, 1363-1374
60. Zagotta, I., Dimova, E.Y., Funcke, J.B., Wabitsch, M., Kietzmann, T., and Fischer-Posovszky, P. (2013). Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue. Oxid Med. Cell. Longev 2013, 793525
61. Zhu, X., Liu, Q., Wang, M., Liang, M., Yang, X., Xu, X., Zou, H., and Qiu, J. (2011). Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 6, e27081